Reneo Pharmaceuticals (RPHM) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free RPHM Stock Alerts $1.90 +0.15 (+8.57%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 5:56 AM | americanbankingnews.comBraden Michael Leonard Purchases 414,281 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) StockMay 17 at 12:08 PM | insidertrades.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Acquires 414,281 SharesMay 17 at 2:14 AM | americanbankingnews.comBrokerages Set Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Price Target at $18.14May 16, 2024 | marketbeat.comInsider Buying: Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Acquires 414,281 Shares of StockReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) major shareholder Braden Michael Leonard purchased 414,281 shares of the company's stock in a transaction that occurred on Tuesday, May 14th. The stock was bought at an average price of $1.54 per share, for a total transaction of $637,992.74. Following the transaction, the insider now directly owns 2,672,194 shares in the company, valued at $4,115,178.76. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Large shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC.May 16, 2024 | americanbankingnews.comHC Wainwright Reiterates Neutral Rating for Reneo Pharmaceuticals (NASDAQ:RPHM)May 14, 2024 | markets.businessinsider.comMitchell Kapoor’s Hold Rating on Reneo Pharmaceuticals Amid OnKure Merger and Oncology Pipeline PotentialMay 14, 2024 | businesswire.comRENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHMMay 14, 2024 | marketbeat.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Receives Average Rating of "Reduce" from BrokeragesReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) has been given an average rating of "Reduce" by the eight ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and seven have assigned a hold rating to thMay 14, 2024 | marketbeat.comReneo Pharmaceuticals (NASDAQ:RPHM) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reiterated a "neutral" rating and issued a $1.50 price objective on shares of Reneo Pharmaceuticals in a report on Tuesday.May 13, 2024 | prnewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHMMay 13, 2024 | finance.yahoo.comReneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares RiseMay 13, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, RPHMMay 13, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Reneo Pharmaceuticals, Inc. has obtained a Fair Price in its Transaction with OnKureMay 13, 2024 | businesswire.comRPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to ShareholdersMay 13, 2024 | markets.businessinsider.comReneo Pharmaceuticals, OnKure To MergeMay 13, 2024 | marketwatch.comReneo Pharmaceuticals Sets Reverse Merger With OnKureMay 13, 2024 | msn.comReneo Pharmaceuticals gains on deal to merge with OnKureMay 13, 2024 | globenewswire.comReneo Pharmaceuticals and OnKure Announce Proposed MergerMay 11, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Decreased by AnalystMay 10, 2024 | markets.businessinsider.comMaintaining Hold on Reneo Pharmaceuticals Amidst Strategic Uncertainties and Pipeline SetbacksMay 10, 2024 | marketbeat.comQ2 2024 EPS Estimates for Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Reduced by AnalystReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Free Report) - Analysts at Leerink Partnrs dropped their Q2 2024 EPS estimates for shares of Reneo Pharmaceuticals in a report issued on Tuesday, May 7th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will post earnings of ($0.22)May 7, 2024 | finanznachrichten.deReneo Pharmaceuticals, Inc.: Reneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 7, 2024 | investorplace.comRPHM Stock Earnings: Reneo Pharmaceuticals Beats EPS for Q1 2024May 7, 2024 | finance.yahoo.comReneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 7, 2024 | globenewswire.comReneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsApril 24, 2024 | marketbeat.comBML Capital Management LLC Makes New Investment in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)BML Capital Management LLC bought a new position in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,314,229 shares of the company's stock, valued at approximatelyApril 14, 2024 | thestreet.comReneo Pharmaceuticals Inc.April 3, 2024 | marketbeat.comReneo Pharmaceuticals (NASDAQ:RPHM) Trading Up 0.6%Reneo Pharmaceuticals (NASDAQ:RPHM) Trading Up 0.6%March 31, 2024 | markets.businessinsider.comSell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price TargetMarch 28, 2024 | benzinga.comReneo Pharmaceuticals: Q4 Earnings InsightsMarch 28, 2024 | investorplace.comRPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023March 28, 2024 | finanznachrichten.deReneo Pharmaceuticals, Inc.: Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business UpdateMarch 28, 2024 | globenewswire.comReneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business UpdateFebruary 14, 2024 | uk.finance.yahoo.comReneo Pharmaceuticals, Inc. (RPHM)February 14, 2024 | uk.finance.yahoo.comReneo Pharmaceuticals, Inc. (RPHM)February 2, 2024 | marketbeat.comReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Receives Consensus Recommendation of "Reduce" from BrokeragesReneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) has been given an average rating of "Reduce" by the eight brokerages that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating and seven have issued a hold rating on the company.January 30, 2024 | investing.comReneo Pharmaceuticals Inc (RPHM)December 27, 2023 | msn.comWhy Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionDecember 19, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Rain Therapeutics (RAIN), Reneo Pharmaceuticals (RPHM) and Bicycle Therapeutics (BCYC)December 16, 2023 | markets.businessinsider.comHold Rating on Reneo Pharmaceuticals Following Lead Drug Trial Failure and Strategic UncertaintyDecember 16, 2023 | msn.comJefferies Downgrades Reneo Pharmaceuticals (RPHM)December 15, 2023 | finance.yahoo.comReneo (RPHM) Plummets 83% on Failure of Metabolic Disorder StudyDecember 15, 2023 | marketbeat.comReneo Pharmaceuticals (NASDAQ:RPHM) Rating Reiterated by Jefferies Financial GroupJefferies Financial Group restated a "hold" rating and issued a $1.80 price target (down from $17.00) on shares of Reneo Pharmaceuticals in a research note on Friday.December 15, 2023 | realmoney.thestreet.comReneo Pharmaceuticals just downgraded at BofA, here's whyDecember 15, 2023 | markets.businessinsider.com5 Analysts Have This to Say About Reneo PharmaceuticalsDecember 15, 2023 | realmoney.thestreet.comReneo Pharmaceuticals just downgraded at Piper Sandler, here's whyDecember 15, 2023 | realmoney.thestreet.comReneo Pharmaceuticals just downgraded at Leerink, here's whyDecember 14, 2023 | marketwatch.comReneo Pharma Hits All-Time Low on Job Cuts, Halted Mavodelpar DevelopmentDecember 14, 2023 | msn.comReneo stock plunges 84% as company shuts down lead programDecember 14, 2023 | finance.yahoo.comWhy Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today? Get Reneo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. RPHM Media Mentions By Week RPHM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPHM News Sentiment▼0.440.42▲Average Medical News Sentiment RPHM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPHM Articles This Week▼111▲RPHM Articles Average Week Get Reneo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EQ News Today CKPT News Today BLRX News Today RVPH News Today KZR News Today TLSA News Today BOLT News Today ELDN News Today IMMX News Today RMTI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPHM) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyThe #1 Crypto for AIWeiss Ratings**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
